| 1 |
25418492 | Role of RAAS and adipokines in cardiovascular protection: effect of different doses of angiotensin II receptor blocker on adipokines level in hypertensive patients. | 2014 Oct |
1 |
| 2 |
19059660 | Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs. | 2010 Apr 1 |
1 |
| 3 |
20493430 | Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus. | 2010 Jun |
1 |
| 4 |
20505674 | Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients. | 2010 Aug |
1 |
| 5 |
20823643 | Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients. | 2010 |
1 |
| 6 |
17483542 | Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients. | 2007 Jun |
2 |
| 7 |
16246439 | Anti-inflammatory and metabolic effects of candesartan in hypertensive patients. | 2006 Mar 22 |
2 |
| 8 |
16443859 | Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients. | 2006 Feb |
1 |
| 9 |
16940715 | Impact of angiotensin II receptor blocker on plasma levels of adiponectin and advanced oxidation protein products in peritoneal dialysis patients. | 2006 |
2 |
| 10 |
12796280 | Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. | 2003 Jul |
1 |